FDA Commissioner Marty Makary said publishing complete response letters recognizes public interest in the transparency and credibility of agency decision-making about drugs. He also said the move complies with an executive order that covers the communication of scientific data.
The post Embracing Transparency, FDA Will Make All Future Drug Rejection Letters Public appeared first on MedCity News.
